Addressing the challenges of GDM detection and management in low resources-settings
India is one of the diabetes capitals of the world, and has among the highest rates of women with GDM, with more than 5 million women affected in the country each year. At 66 million, India currently has the second highest number of people with type 2 diabetes in the world; almost half of these cases are women. IDF estimates that 6 million births are affected by some form of hyperglycaemia in pregnancy in India alone, of which 90% are due to GDM.
The IDF Women in India with GDM Strategy (WINGS) project was the first-ever strategy to tackle the rising prevalence of GDM in India. This project aimed to develop a context-adapted model approach to care in low-resource settings which confronts the widespread challenges in GDM screening and management. The project developed a standardised approach to GDM care, seeking to improve the health outcomes of women with GDM and their new-borns, strengthening the capacity of selected health facilities to address GDM. This included developing additional materials for health outreach workers.
The WINGS project was developed through a partnership between the IDF, the Madras Diabetes Research Foundation (MDRF) in Chennai, India, and the Abbott Fund, the philanthropic foundation of the global healthcare company Abbott. Seven rural and urban collaborating health centres were identified in Tamil Nadu State (South India). An Expert Committee was set up to advise the project implementation according to a two-step process that involved:
Developing a curriculum and accompanying tools to train healthcare professionals (HCPs) and women on GDM screening and management (multidisciplinary target group of physicians, diabetologists, dieticians, nurses)
Developing a context-specific model of care for GDM, incorporating a curriculum.
Following implementation of the IDF WINGS Model of Care for GDM, women with GDM were found to have pregnancy outcomes comparable to women without GDM. These positive results suggest that the IDF Model of Care was successful in preventing adverse outcomes in Women with GDM.
The IDF WINGS Model of Care for GDM offers a comprehensive package of tools for every level of care which includes guides for health care professionals providing care for women diagnosed with GDM, community health workers who follow up women in remote areas having limited medical access and also to pregnant women with educational games to improve awareness on GDM.
Click on the images below to download the elements of the IDF WINGS educational toolkit.
IDF has an extensive network of advocates and supporters, who are key in the success of the IDF advocacy campaigns and activities. The IDF Members, Blue Circle Voices and Young Leaders in Diabetes are instrumental in sharing our key messages at the global level and in promoting our campaigns at the national and regional levels.
IDF's network of Members in 168 countries provides an authoritative global voice, working to ensure that the needs of all people affected by diabetes are met so that each can live their lives as unhindered by the disease as possible. You can read more about the IDF Members here.
Blue Circle Voices
Blue Circle Voices (BCV) is an IDF network launched in 2016 that aims to represent the interests of people living with, or affected by, diabetes, through a worldwide network of members and other stakeholders. The BCV network acts as the global voice of people living with diabetes and draws upon their experiences. You can read more about the BCV network here.
Young Leaders in Diabetes
The IDF Young Leaders in Diabetes (YLD) Programme was established in 2011 to empower young people living with diabetes to become advocates for themselves and others living with diabetes worldwide. You can read more about the YLD network here.
Below you can find information about some of the advocacy campaigns that IDF ran in 2017.
Policy recommendations to improve access to diabetes care in Brazil, South Africa and Russia
On the occasion of the BRICS Leaders’ Summit, which took place between 3-5 September 2017 in China, IDF worked with its Members and BCV members in Brazil, South Africa and Russia to develop policy recommendations to improve access to diabetes care in their countries. The recommendations can be downloaded by clicking on the images below.
Brazil - English
Brazil - Portuguese
Russia - English
IDF online campaigns on occasion of the G7 and the G20 leaders' summit
Kidney disease (nephropathy) is far more common in people with diabetes than in people without diabetes. It is caused by damage to small blood vessels, which can cause the kidneys to be less efficient, or to fail altogether. Diabetes is one of the leading causes of chronic kidney disease (CKD).
Based on data from the UK and USA, up to 40% of people with diabetes will develop chronic kidney disease.1 Pooled data from 54 countries reveal that more than 80% of cases of end-stage renal disease (ESRD) are caused by diabetes, hypertension or a combination of both.
Diabetes, hypertension and kidney failure are highly interlinked. On the one hand, type 2 diabetes is a leading cause of kidney failure, which is a risk for hypertension, and on the other, hypertension can often precede CKD and contribute to the progression of kidney disease.
Both diabetes and CKD are strongly associated with cardiovascular disease (CVD) and therefore, the major component in their management is control of CVD risk factors such as hypertension and high blood glucose (hyperglycaemia). It is important to control blood glucose and blood pressure to reduce the risk of kidney disease. Screening for abnormal quantities of albumin in the urine (albuminuria) and starting treatment with drugs that reduce the activity of the renin-angiotensin-aldosterone system when albuminuria is persistently found, even in the absence of hypertension, is very effective to prevent the development and progression of CKD in people with diabetes.
Screening for albuminuria should be done every year after diagnosis in people with type 2 diabetes and the same after the first five years in people with type 1 diabetes.
IDF diabetes and kidney resources
IDF's international network for health professionals - D-NET - offers a free online education module on "Understanding Diabetic Kidney Disease". Click on the image below to access the module.